Head and Neck Squamous Cell Carcinoma
Showing 9976 - 10000 of >10,000
Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)
Active, not recruiting
- Non Small Cell Lung Cancer
- +5 more
-
Orange, California
- +13 more
Nov 7, 2022
Renal Cell Carcinoma Trial in Scottsdale (questionnaire)
Completed
- Renal Cell Carcinoma
- questionnaire
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jun 15, 2020
Abdominal Aortic Aneurysm (AAA) Trial in Worldwide (endovascular repair of the AAA)
Recruiting
- Abdominal Aortic Aneurysm (AAA)
- endovascular repair of the AAA
-
Paris, France
- +10 more
Jan 28, 2021
Immunological Pure Red Cell Aplasia Trial (Isatuximab)
Not yet recruiting
- Immunological Pure Red Cell Aplasia
- (no location specified)
Sep 26, 2022
Visualizing Beta Cells After Bariatric Surgery
Recruiting
- Type 2 Diabetes Mellitus
- 68Ga-exendin PET/CT
-
Arnhem, Gelderland, Netherlands
- +1 more
Jun 16, 2022
Asthma, Allergic Trial in Boston (Bronchoscopy/BAL, Airway Brushing)
Recruiting
- Asthma, Allergic
- Bronchoscopy/BAL
- Airway Brushing
-
Boston, MassachusettsMassachusetts General Hospital
Sep 6, 2022
Multi- Target Hepatocellular Carcinoma Test in Increased Risk
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Study CT/MRI Imaging
- +2 more
-
Chandler, Arizona
- +33 more
May 27, 2022
Lymphoma Trial in New York (rituximab, bendamustine, melphalan)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)
Active, not recruiting
- Leukemia, Myeloid, Acute
-
Coimbra, Portugal
- +63 more
Sep 9, 2022
Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,
Suspended
- Burkitt Lymphoma
- +4 more
- Rituximab
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Advanced Hepatocellular Carcinoma Trial (Adebrelimab, Bevacizumab, SHR-8068)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Adebrelimab
- +2 more
- (no location specified)
Jun 30, 2022
Late Dysphagia in Oropharynx and Nasopharynx Cancer, Candidates
Recruiting
- Cancer of Oropharynx
- Cancer of Nasopharynx
-
Pisa, ItalyAzienda Ospedaliero Universitaria Pisana
Jan 13, 2020
Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 6, 2022
Multiple Myeloma Trial in Birmingham (Multi-modal Exercise Regimen, Dietary Guidelines)
Not yet recruiting
- Multiple Myeloma
- Multi-modal Exercise Regimen
- Dietary Guidelines
-
Birmingham, AlabamaKirklin Clinic of UAB Hospital
Nov 29, 2022
Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)
Enrolling by invitation
- Peripheral T-cell Lymphoma Targeted Therapy
- Azacitidine
- +5 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023
Refractory Peripheral T-Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma Trial in Belgium, France (Brentuximab Vedotin -
Completed
- Refractory Peripheral T-Cell Lymphoma
- Relapsed Peripheral T-Cell Lymphoma
- Brentuximab Vedotin - induction
- +3 more
-
Antwerpen, Belgium
- +38 more
Jan 9, 2023
Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Tislelizumab, Ablation)
Recruiting
- Recurrent Hepatocellular Carcinoma
- Tislelizumab
- Ablation
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 21, 2021
Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)
Recruiting
- Acute Myeloid Leukemia
- Decitabine and Cedazuridine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Diabetes, Diabetes, Proliferative Diabetic Retinopathy Trial in Aarhus
Recruiting
- Diabetes
- +4 more
-
Aarhus, DenmarkSteno Diabetes Center Aarhus, Aarhus University Hospiral
Dec 23, 2021
Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)
Not yet recruiting
- Postoperative Prevention of Tumor
- Oral NMN combined with DC cell vaccine
-
Shanghai, Shanghai, ChinaShanghai Mengchao Cancer Hospital
Sep 6, 2023
Hematopoietic and Lymphoid Cell Tumor Trial in United States (Best Practice and Internet site with links to existing resources,
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Best Practice and Internet site with links to existing resources
- +2 more
-
Tampa, Florida
- +14 more
Dec 5, 2022
Imaging Order to 2020 French Guidelines for Cervical Spine
Active, not recruiting
- Cervical Spine Injury
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Dec 8, 2022
Locally Advanced or Metastatic Urothelial Carcinoma Trial in Spain (Atezolizumab 1200 mg/m2, Gemcitabine 1000 mg/m2, Cisplatin
Active, not recruiting
- Locally Advanced or Metastatic Urothelial Carcinoma
- Atezolizumab 1200 mg/m2
- +2 more
-
Barcelona, Spain
- +11 more
Mar 24, 2022
Sickle Cell Disease Trial in Cairo (L-Glutamine, Oral Powder for Reconstitution, Standard of care)
Recruiting
- Sickle Cell Disease
- L-Glutamine, Oral Powder for Reconstitution
- Standard of care
-
Cairo, Non-US, Egypt
- +1 more
May 7, 2022
Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])
Completed
- Bronchiolitis Obliterans
- Graft Vs Host Disease
- Pirfenidone 267 MG [Esbriet]
-
Palo Alto, CaliforniaStanford University School of Medicine
Jun 8, 2022